Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]
SEC Accession No. 0001493152-24-033650
Filing Date
2024-08-23
Accepted
2024-08-23 09:25:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 form8-a12ba.htm 8-A12B/A 25362
  Complete submission text file 0001493152-24-033650.txt   26402
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-A12B/A | Act: 34 | File No.: 001-42212 | Film No.: 241233738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)